140 related articles for article (PubMed ID: 29909343)
1. Tanshinone IIA inhibits cervix carcinoma stem cells migration and invasion via inhibiting YAP transcriptional activity.
Qin J; Shi H; Xu Y; Zhao F; Wang Q
Biomed Pharmacother; 2018 Sep; 105():758-765. PubMed ID: 29909343
[TBL] [Abstract][Full Text] [Related]
2. Knockdown of HuR represses osteosarcoma cells migration, invasion and stemness through inhibition of YAP activation and increases susceptibility to chemotherapeutic agents.
Xu W; Chen C; Xu R; Li Y; Hu R; Li Z; Zhu X
Biomed Pharmacother; 2018 Jun; 102():587-593. PubMed ID: 29597092
[TBL] [Abstract][Full Text] [Related]
3. Metformin inhibits glioma cells stemness and epithelial-mesenchymal transition via regulating YAP activity.
Yuan X; Wei W; Bao Q; Chen H; Jin P; Jiang W
Biomed Pharmacother; 2018 Jun; 102():263-270. PubMed ID: 29567539
[TBL] [Abstract][Full Text] [Related]
4. lncRNA B4GALT1-AS1 promotes colon cancer cell stemness and migration by recruiting YAP to the nucleus and enhancing YAP transcriptional activity.
Zhang Y; Fang Z; Guo X; Dong H; Zhou K; Huang Z; Xiao Z
J Cell Physiol; 2019 Aug; 234(10):18524-18534. PubMed ID: 30912138
[TBL] [Abstract][Full Text] [Related]
5. LncRNA THOR attenuates cisplatin sensitivity of nasopharyngeal carcinoma cells via enhancing cells stemness.
Gao L; Cheng XL; Cao H
Biochimie; 2018 Sep; 152():63-72. PubMed ID: 29959065
[TBL] [Abstract][Full Text] [Related]
6. Limonin attenuates the stemness of cervical carcinoma cells by promoting YAP nuclear-cytoplasmic translocation.
Zhao W; Wu M; Cui L; Du W
Food Chem Toxicol; 2019 Mar; 125():621-628. PubMed ID: 30738134
[TBL] [Abstract][Full Text] [Related]
7. Tanshinone IIA inhibits gastric cancer cell stemness through inducing ferroptosis.
Ni H; Ruan G; Sun C; Yang X; Miao Z; Li J; Chen Y; Qin H; Liu Y; Zheng L; Xing Y; Xi T; Li X
Environ Toxicol; 2022 Feb; 37(2):192-200. PubMed ID: 34661962
[TBL] [Abstract][Full Text] [Related]
8. Statin suppresses Hippo pathway-inactivated malignant mesothelioma cells and blocks the YAP/CD44 growth stimulatory axis.
Tanaka K; Osada H; Murakami-Tonami Y; Horio Y; Hida T; Sekido Y
Cancer Lett; 2017 Jan; 385():215-224. PubMed ID: 27773750
[TBL] [Abstract][Full Text] [Related]
9. Tanshinone IIA inhibits the growth, attenuates the stemness and induces the apoptosis of human glioma stem cells.
Yang L; Guo H; Dong L; Wang L; Liu C; Wang X
Oncol Rep; 2014 Sep; 32(3):1303-11. PubMed ID: 24970314
[TBL] [Abstract][Full Text] [Related]
10. LncRNA B4GALT1-AS1 recruits HuR to promote osteosarcoma cells stemness and migration via enhancing YAP transcriptional activity.
Li Z; Wang Y; Hu R; Xu R; Xu W
Cell Prolif; 2018 Dec; 51(6):e12504. PubMed ID: 30182452
[TBL] [Abstract][Full Text] [Related]
11. Tanshinone IIA mediates SMAD7-YAP interaction to inhibit liver cancer growth by inactivating the transforming growth factor beta signaling pathway.
Ma L; Jiang H; Xu X; Zhang C; Niu Y; Wang Z; Tao Y; Li Y; Cai F; Zhang X; Wang X; Yu Y
Aging (Albany NY); 2019 Nov; 11(21):9719-9737. PubMed ID: 31711043
[TBL] [Abstract][Full Text] [Related]
12. The Long Non-Coding RNA MALAT1 Enhances Ovarian Cancer Cell Stemness by Inhibiting YAP Translocation from Nucleus to Cytoplasm.
Wu X; Wang Y; Zhong W; Cheng H; Tian Z
Med Sci Monit; 2020 May; 26():e922012. PubMed ID: 32433460
[TBL] [Abstract][Full Text] [Related]
13. Tanshinone IIA attenuates the stemness of breast cancer cells via targeting the miR-125b/STARD13 axis.
Li X; Jia Q; Zhou Y; Jiang X; Song L; Wu Y; Wang A; Chen W; Wang S; Lu Y
Exp Hematol Oncol; 2022 Jan; 11(1):2. PubMed ID: 35057866
[TBL] [Abstract][Full Text] [Related]
14. Long noncoding RNA MALAT1 promotes the stemness of esophageal squamous cell carcinoma by enhancing YAP transcriptional activity.
Yao Q; Yang J; Liu T; Zhang J; Zheng Y
FEBS Open Bio; 2019 Aug; 9(8):1392-1402. PubMed ID: 31116509
[TBL] [Abstract][Full Text] [Related]
15. Tanshinone IIA induced cell death via miR30b-p53-PTPN11/SHP2 signaling pathway in human hepatocellular carcinoma cells.
Ren X; Wang C; Xie B; Hu L; Chai H; Ding L; Tang L; Xia Y; Dou X
Eur J Pharmacol; 2017 Feb; 796():233-241. PubMed ID: 27894814
[TBL] [Abstract][Full Text] [Related]
16. Tanshinone IIA combined with adriamycin inhibited malignant biological behaviors of NSCLC A549 cell line in a synergistic way.
Xie J; Liu JH; Liu H; Liao XZ; Chen Y; Lin MG; Gu YY; Liu TL; Wang DM; Ge H; Mo SL
BMC Cancer; 2016 Nov; 16(1):899. PubMed ID: 27863471
[TBL] [Abstract][Full Text] [Related]
17. Tanshinone IIA Inhibits Epithelial-Mesenchymal Transition in Bladder Cancer Cells via Modulation of STAT3-CCL2 Signaling.
Huang SY; Chang SF; Liao KF; Chiu SC
Int J Mol Sci; 2017 Jul; 18(8):. PubMed ID: 28757590
[TBL] [Abstract][Full Text] [Related]
18. Tanshinone IIA inhibits metastasis after palliative resection of hepatocellular carcinoma and prolongs survival in part via vascular normalization.
Wang WQ; Liu L; Sun HC; Fu YL; Xu HX; Chai ZT; Zhang QB; Kong LQ; Zhu XD; Lu L; Ren ZG; Tang ZY
J Hematol Oncol; 2012 Nov; 5():69. PubMed ID: 23137165
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of cytochrome P450 2J2 by tanshinone IIA induces apoptotic cell death in hepatocellular carcinoma HepG2 cells.
Jeon YJ; Kim JS; Hwang GH; Wu Z; Han HJ; Park SH; Chang W; Kim LK; Lee YM; Liu KH; Lee MY
Eur J Pharmacol; 2015 Oct; 764():480-488. PubMed ID: 26209360
[TBL] [Abstract][Full Text] [Related]
20. Limonin suppresses the progression of oral tongue squamous cell carcinoma via inhibiting YAP transcriptional regulatory activity.
Yang G; Li Z; Chen L
Tissue Cell; 2020 Aug; 65():101346. PubMed ID: 32746992
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]